Appendix S1. Defining symptom-focused medications â introduction. Appendix S2. Defining symptom-focused medications â drug class coding. Appendix S3. Full multivariable model comparing medication change outcomes in intervention and control subjects. Appendix S4. Distribution of medication classes used at baseline, and of medication classes that were changed between baseline and 9Â months. Appendix S5. Relationship between number of medication changes and patient-centeredness of treatment planning (3-item PACIC score), in control group. (DOCX 53 kb
Univariate linear regression of effects of home-based long-term care service use on self-rated healt...
Supplementary 1. Network meta-analysis model. Supplementary 2. References for included trials. Suppl...
Questionnaire asking patients about engagement in advance care planning. (DOCX 37Â kb
BASELINE medication use and cost in 2007 – Means and standard deviations. Baseline medication use an...
Tables S1, S2_1, S2_2, S2_3 and S2_4. Table S1 shows effect on location on use of psychotropic drugs...
Sequential changes of patient’s status according to the administration of psychotropic drugs at Bord...
Table S1. The different psychotropic medications, defined according to the Australian Medicines Hand...
Details of the re-design of the intervention in preparation for this trial. (DOCX 28Â kb
Number of all regular medications, according to the medication appropriateness list [1] and the WHO-...
Results of sensitivity analyses. The file contains two tables (Tables S1 and S2) presenting the resu...
eTable 1. The care facilities of study subjects during the index acute myocardial infarction. eTable...
Focus group discussion guide. A data collection tool used during focus group discussion with pharmac...
A complete presentation of our analysis, with univariate and multivariate mixed models, including th...
Median (Interquartile range (IQR)) absolute bias (%) for treatment effect, β1 for different approac...
The DA VINCI Pharmacotherapy Algorithm. The Supplement contains a description of the DA VINCI Pharma...
Univariate linear regression of effects of home-based long-term care service use on self-rated healt...
Supplementary 1. Network meta-analysis model. Supplementary 2. References for included trials. Suppl...
Questionnaire asking patients about engagement in advance care planning. (DOCX 37Â kb
BASELINE medication use and cost in 2007 – Means and standard deviations. Baseline medication use an...
Tables S1, S2_1, S2_2, S2_3 and S2_4. Table S1 shows effect on location on use of psychotropic drugs...
Sequential changes of patient’s status according to the administration of psychotropic drugs at Bord...
Table S1. The different psychotropic medications, defined according to the Australian Medicines Hand...
Details of the re-design of the intervention in preparation for this trial. (DOCX 28Â kb
Number of all regular medications, according to the medication appropriateness list [1] and the WHO-...
Results of sensitivity analyses. The file contains two tables (Tables S1 and S2) presenting the resu...
eTable 1. The care facilities of study subjects during the index acute myocardial infarction. eTable...
Focus group discussion guide. A data collection tool used during focus group discussion with pharmac...
A complete presentation of our analysis, with univariate and multivariate mixed models, including th...
Median (Interquartile range (IQR)) absolute bias (%) for treatment effect, β1 for different approac...
The DA VINCI Pharmacotherapy Algorithm. The Supplement contains a description of the DA VINCI Pharma...
Univariate linear regression of effects of home-based long-term care service use on self-rated healt...
Supplementary 1. Network meta-analysis model. Supplementary 2. References for included trials. Suppl...
Questionnaire asking patients about engagement in advance care planning. (DOCX 37Â kb